Preclinical molecule development is a crucial step in bringing innovative therapies to patients. Maximizing the potency of these therapies requires comprehensive understanding of their pharmacokinetic (PK) and pharmacodynamic (PD) properties. Comprehensive preclinical DMPK services offer a broad range of studies designed to characterize the fate a